Improvement of migratory defects in a murine model of Wiskott-Aldrich syndrome gene therapy (Q33379160)

26 July 2017

title

Improvement of migratory defects in a murine model of Wiskott-Aldrich syndrome gene therapy (English)

1 reference

26 July 2017

main subject

Wiskott-Aldrich syndrome

0 references

0 references

1 reference

Gerben Bouma

2

0 references

Gareth E. Jones

object named as

Gareth E Jones

series ordinal

4

0 references

Adrian Thrasher

object named as

Adrian J Thrasher

series ordinal

6

0 references

Yolanda Calle

series ordinal

3

object named as

Yolanda Calle

1 reference

26 July 2017

5

Christine Kinnon

1 reference

26 July 2017

1

Michael P Blundell

1 reference

26 July 2017

publication date

18 March 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

16

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

836-844

1 reference

WASp in immune-system organization and function

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

The Wiskott-Aldrich syndrome protein: forging the link between actin and cell activation

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Mechanisms of WASp-mediated hematologic and immunologic disease.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Inhibition of calpain stabilises podosomes and impairs dendritic cell motility

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Cellular dynamics in the draining lymph nodes during sensitization and elicitation phases of contact hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

CD8+ T cells produce IL-2, which is required for CD(4+)CD25+ T cell regulation of effector CD8+ T cell development for contact hypersensitivity responses

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.43

7 January 2021

Identifiers

DOI

10.1038/MT.2008.43

1 reference

release_zv3wrbiy3fghbhz6lzn3rydgzm

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zv3wrbiy3fghbhz6lzn3rydgzm

24 November 2022

mapped directly with Wikidata item

1 reference